Hints and tips:
...Nath took over Smith & Nephew last year, promising to turn around its struggling orthopaedics division. The company’s other divisions, sports medicine and wound management, outperform the market....
...News round-up Smith & Nephew seeks pay premium for US executives over those in UK (FT) Thomson Reuters has $8bn war chest for AI-focused deals, says chief (FT) Elliott abandons effort to buy UK electronics...
...For the 2023 financial year, Smith & Nephew is targeting revenue growth and trading profit margins above last year’s levels....
...Roland Diggelmann, chief executive of device maker Smith & Nephew, who previously led diagnostics for Roche, does not see the lack of publications as a weakness, arguing it is normal for a diagnostics maker...
...Nath, who was previously president of diagnostics at Siemens Healthineers, will take the reins at Smith & Nephew from April 1....
...The announcement of the new chief came as Smith & Nephew’s fourth quarter revenues missed analysts’ expectations, with sales in its orthopaedics business hampered by global supply chain disruption....
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...Smith & Nephew posted a 12.1 per cent drop in underlying revenue for 2020 and cautioned that disruption from Covid-19 was likely to continue for the first half of 2021....
...Smith+Nephew, the orthopaedic device maker, said it expects a fourth quarter underlying revenue decline of approximately 7 per cent....
...Smith & Nephew goes up to “overweight” at Morgan Stanley. A V-shaped recovery in kneecaps isn’t in the price, they say....
...Medical device manufacturer Smith Nephew has raised its revenue guidance for a second successive quarter, driven by strong growth in its sports medicine and orthopaedics businesses....
...At Smith & Nephew, his base salary this year is about $1.5m, with a total package of about $6m if all targets are met....
...Perennial picks include medical device maker Smith & Nephew, tobacco company Imperial Brands and broadcaster ITV....
...Medical device maker Smith & Nephew signalled more acquisitions after reporting a rise in first-quarter revenue and lifting its full-year guidance....
...When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity....
...Smith & Nephew has forged a $660m deal to buy Osiris Therapeutics as the FTSE 100 medical equipment maker looks to acquisitions to reinvigorate and diversify its business....
...Namal Nawana: competitive spirit UK medical devices maker Smith & Nephew seems keen to shift its listing to the US. That would give it a freer rein to raise the pay of chief exec Namal Nawana....
...A unit of Paul Singer’s aggressive activist fund Elliott Management has pushed for UK medical device maker Smith & Nephew to shed certain parts of its business, in a move that could make the company a more...
...Nawana departure wounds Smith & Nephew Close DD followers will have seen a few stories over the past year about UK medical devices group Smith & Nephew....
...The UK’s Smith & Nephew has mulled buying smaller rival NuVasive. In this sense, Medacta does not offer much of a future thrill....
...Smith & Nephew beat the day’s sell-off with the orthopaedics maker hitting a record high on earnings and brighter than expected guidance....
...Philip Mallinckrodt, Bruno’s nephew, has been a director for nearly 10 years, and during his second stint at the business became head of private assets and wealth management....
...& Nephew’s scale”....
...Smith & Nephew, another Elliott target, jumped to a five-month high amid a retread of takeover speculation around the orthopaedic devices maker....
...Mr Nawana takes over as Smith & Nephew is facing pressure from activist investor Elliott Advisors, which has been pressing for divestments....
International Edition